The Anterior Approach of the Combined Lumbar and Sacral Plexuses Block for Analgesia of Lower Limb Surgeries

May 23, 2024 updated by: Naglaa Fathy Abdelhaleem Abdelhaleem, Zagazig University

The One-Point Puncture Anterior Approach of the Combined Lumbar and Sacral Plexuses Block for Analgesia of Lower Limb Orthopedic Surgeries

lumbosacral plexus block (LSPB) has been widely applied in orthopedics departments due to its advantages, including reduction in the application of opiates, decreasing the occurrence of acute pain, promoting early activation, and shortening the time of hospital stay. LSPB is a peripheral regional technique of anesthesia and analgesia, that provides a block of the main components of the lumbosacral plexus.

Study Overview

Status

Enrolling by invitation

Conditions

Detailed Description

Traditional ultrasound-guided lumbar plexus block combined with sacral plexus block requires separate blocks at different sites, requiring the lateral decubitus or prone position, which may be suboptimal in patients with severe pain. we present an anterior approach for combined lumbar and sacral plexus blocks with a one-point puncture.

Study Type

Interventional

Enrollment (Estimated)

56

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Zagazig, Egypt, 44519
        • Faculty of Medicine - Zagazig University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ASA I-II.
  • patients diagnosed with lower limb fracture by X-ray or CT examination necessitate intraoperative tourniquet application
  • patients with any contraindications to spinal anesthesia
  • patients who have severe pain hindering changing their position or patients who have spinal fractures
  • patients with the capability of communication

Exclusion Criteria:

  • puncture site infection
  • patients with coagulation disorders
  • patients who refuse to participate or withdraw due to personal reasons
  • allergy to local anesthetics.
  • past surgery at the site of the block
  • drug abuse
  • peripheral vascular insufficiency
  • use of alpha or beta blocker agents
  • Nerve injury of the affected lower limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Control group
patients who will be recruited in the control group will receive general anesthesia only
performing an ultrasound-guided one-point combined Lumbar and sacral plexus block using a one-point puncture. Block success will be assessed using the perfusion index (PI) before and after performing the block
Other Names:
  • No block intervention in control group
Active Comparator: Interventional group
Patients who will be recruited in the Interventional will receive one point combined lumbar and sacral plexus block. then they will receive general anesthesia
performing an ultrasound-guided one-point combined Lumbar and sacral plexus block using a one-point puncture. Block success will be assessed using the perfusion index (PI) before and after performing the block
Other Names:
  • No block intervention in control group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Total intraoperative and postoperative opioid consumption
Time Frame: Total fentanyl used intraoperative and total morphine consumed up to 24 hours postoperative
The total fentanyl doses consumed in the entire operative procedure and morphine consumed for 24 hours postoperative will be calculated.
Total fentanyl used intraoperative and total morphine consumed up to 24 hours postoperative

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
(NRS) score assessment pre-block, 30 min post-block , and postoperatively in the recovery room, and then it will be repeated 3 h, 6h, 12h, and 24, hours
Time Frame: preoperative and postoperatively pain (NRS) score assessment for 24 hours

Numerical Pain Score (NRS) ranges from 0 to 10, where 0 is no pain, and 10 is the worst pain imaginable. Adequate pain control will be considered at Numerical Pain Score (NRS) < 4.

Pain will be assessed using (the NRS) score preoperatively before the block and 30 min post-block, then postoperatively in the recovery room, 3 h, 6h, 12h, and 24 hours.

preoperative and postoperatively pain (NRS) score assessment for 24 hours
Block success assessment using perfusion index (PI) before and after performing the block
Time Frame: Recording Perfusion index readings at baseline and 10, 20, 30 min. post block
Perfusion index (PI) values rise with successful peripheral nerve blocks. If PI is not changed, this means block failure
Recording Perfusion index readings at baseline and 10, 20, 30 min. post block

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Naglaa Abdelhaleem, MD, Faculty of medicine, Zagazig University Hospitals

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 10, 2023

Primary Completion (Estimated)

May 25, 2024

Study Completion (Estimated)

June 1, 2024

Study Registration Dates

First Submitted

August 25, 2023

First Submitted That Met QC Criteria

August 30, 2023

First Posted (Actual)

August 31, 2023

Study Record Updates

Last Update Posted (Actual)

May 28, 2024

Last Update Submitted That Met QC Criteria

May 23, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • IRB#10892

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Lower Limb Fracture

Clinical Trials on one point combined Lumbar and sacral plexus block

3
Subscribe